Top Markets
Coin of the day
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
Rang in Aktien #42806
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and... Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.
Aktienkurs
$0.01
Zuletzt synchronisiert: 2024-08-19
Marktkapitalisierung
$61.27
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Alseres Pharmaceuticals, Inc. (ALSE)

Kategorie

Kursverlauf für Alseres Pharmaceuticals, Inc. (ALSE)
Höchster Schlusskurs: $0.01 am 2024-08-01

Niedrigster Schlusskurs: $29.96K am 1994-12-01
Kursverlauf der Aktie von Alseres Pharmaceuticals, Inc. von 1994 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 0.00%
2023 0.00%
2022 0.00%
2021 -99.83%
2020 -40.00%
2019 -33.33%
2018 -62.96%
2017 -19.00%
2016 -23.08%
2015 -68.82%
2014 23.30%
2013 87.23%
2012 -43.51%
2011 -82.93%
2010 -26.51%
2009 -84.07%
2008 -44.14%
2007 15.21%
2006 17.90%
2005 -30.46%
2004 -53.37%
2003 1.22%
2002 -55.80%
2001 -22.03%
2000 -4.11%
1999 4.07%
1998 65.57%
1997 -66.23%
1996 -2.51%
1995 471.92%
1994 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR